Bank Julius Baer & Co. Ltd Zurich Has $144,000 Stake in UnitedHealth Group Incorporated $UNH

Bank Julius Baer & Co. Ltd Zurich lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 44.1% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 463,041 shares of the healthcare conglomerate’s stock after selling 364,616 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich owned approximately 0.05% of UnitedHealth Group worth $144,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of the company. HHM Wealth Advisors LLC raised its stake in UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after buying an additional 26 shares during the period. Hemington Wealth Management increased its holdings in shares of UnitedHealth Group by 2.5% during the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock worth $604,000 after acquiring an additional 28 shares during the last quarter. Tlwm lifted its holdings in UnitedHealth Group by 1.0% during the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock valued at $1,433,000 after purchasing an additional 28 shares during the last quarter. Evermay Wealth Management LLC increased its holdings in shares of UnitedHealth Group by 1.2% in the first quarter. Evermay Wealth Management LLC now owns 2,413 shares of the healthcare conglomerate’s stock valued at $1,264,000 after purchasing an additional 29 shares during the last quarter. Finally, MGO One Seven LLC lifted its stake in shares of UnitedHealth Group by 0.3% during the 1st quarter. MGO One Seven LLC now owns 8,781 shares of the healthcare conglomerate’s stock worth $4,599,000 after buying an additional 30 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research analysts have weighed in on UNH shares. KeyCorp increased their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a report on Wednesday, October 8th. Truist Financial increased their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research note on Tuesday, September 9th. Morgan Stanley upped their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Deutsche Bank Aktiengesellschaft downgraded UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price for the company. in a report on Wednesday, October 29th. Finally, Jefferies Financial Group raised their price target on shares of UnitedHealth Group from $317.00 to $409.00 and gave the stock a “buy” rating in a research report on Friday, October 17th. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $397.12.

UnitedHealth Group Stock Performance

NYSE UNH opened at $318.89 on Tuesday. The firm’s 50 day simple moving average is $344.10 and its 200 day simple moving average is $315.39. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $622.83. The firm has a market capitalization of $288.86 billion, a price-to-earnings ratio of 16.64, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The firm had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. During the same quarter last year, the business posted $7.15 EPS. The company’s revenue was up 12.2% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be issued a $2.21 dividend. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. UnitedHealth Group’s dividend payout ratio is 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.